H. Goossens
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2002–2021
A researcher in the Science corpus: 18 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom H. Goossens trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts H. Goossens overall
Papers from H. Goossens's perspective
Ordered by how strongly the researchers H. Goossens trusts endorse each paper. Same corpus, a different order for every researcher.
- InterProScan: protein domains identifier (Nucleic Acids Res.)
- The Pfam protein families database: towards a more sustainable future
- Helicobacter pylori Detection and Antimicrobial Susceptibility Testing (Clinical Microbiology Reviews)
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report (Gut)
- Tipping elements in the Earth's climate system (Proceedings of the National Academy of Sciences of the United States of America)
- Antimicrobials: access and sustainable eff ectiveness 1 Access to eff ective antimicrobials: a worldwide challenge
- Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis (British medical journal)
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. (The Lancet)
- Urbanisation and infectious diseases in a globalised world (Lancet. Infectious Diseases (Print))
- Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. (Lancet. Infectious Diseases (Print))
Their papers
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 (2021) — 704 citations
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 (2021) — 1,528 citations
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 (2021) — 686 citations
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (2020) — 6,734 citations
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. (2020) — 768 citations
- Seasonal coronavirus protective immunity is short-lasting (2020) — 683 citations
- Global increase and geographic convergence in antibiotic consumption between 2000 and 2015 (2018) — 2,750 citations
- Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. (2016) — 727 citations
- A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance (2014) — 1,142 citations
- EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. (2012) — 2,203 citations
- Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption (2012) — 888 citations
- The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. (2012) — 713 citations
- European Position Paper on Rhinosinusitis and Nasal Polyps 2012. (2012) — 1,612 citations
- European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. (2011) — 655 citations
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. (2005) — 3,213 citations
- International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum -Lactamase Production in Nosocomial Infections (2004) — 673 citations
- Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. (2004) — 604 citations
- Community-Acquired Klebsiella pneumoniae Bacteremia: Global Differences in Clinical Patterns (2002) — 596 citations